Mycenax Biotech Inc. (TPEX:4726)
Taiwan
· Delayed Price · Currency is TWD 33.05
+0.40 (1.23%)
Mar 9, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 6.85 billion as of March 9, 2026. Its market cap has decreased by -25.85% in one year.
Market Cap
6.85B
Enterprise Value
7.75B
Revenue
649.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.05
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.85B, an increase of 1,072.39%. That is a compound annual growth rate of 15.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.29B |
| Acepodia | 7.48B |
| Adimmune | 7.67B |
| Sinphar Pharmaceutical | 5.86B |
| Steminent Biotherapeutics | 5.50B |
| CHO Pharma | 5.34B |
| AnnJi Pharmaceutical | 5.30B |
| Locus Cell | 5.30B |